Global Veterinary or Animal Vaccines Market Research Report 2023
Global Veterinary or Animal Vaccines Market Overview:
Global Veterinary or Animal Vaccines Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Veterinary or Animal Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Veterinary or Animal Vaccines Market
The Veterinary or Animal Vaccines Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Veterinary or Animal Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Veterinary or Animal Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Veterinary or Animal Vaccines Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Veterinary or Animal Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Veterinary or Animal Vaccines Market Segmentation
Global Veterinary or Animal Vaccines Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Veterinary or Animal Vaccines market has been segmented into:
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Application, Veterinary or Animal Vaccines market has been segmented into:
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
Other Diseases
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Veterinary or Animal Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Veterinary or Animal Vaccines market.
Top Key Players Covered in Veterinary or Animal Vaccines market are:
Merck Animal Health
Elanco Animal Health
Zoetis Inc. (Pfizer)
Boehringer Ingelheim
Merial Inc.
Ceva Animal Health
Elanco
Virbac Inc.
Bayer Animal Health
Heska Corporation
Phibro Animal Health
Objective to buy this Report:
1. Veterinary or Animal Vaccines analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Veterinary or Animal Vaccines market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Veterinary or Animal Vaccines Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Veterinary or Animal Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Veterinary or Animal Vaccines Market
The Veterinary or Animal Vaccines Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Veterinary or Animal Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Veterinary or Animal Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Veterinary or Animal Vaccines Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Veterinary or Animal Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Veterinary or Animal Vaccines Market Segmentation
Global Veterinary or Animal Vaccines Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Veterinary or Animal Vaccines market has been segmented into:
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Application, Veterinary or Animal Vaccines market has been segmented into:
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
Other Diseases
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Veterinary or Animal Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Veterinary or Animal Vaccines market.
Top Key Players Covered in Veterinary or Animal Vaccines market are:
Merck Animal Health
Elanco Animal Health
Zoetis Inc. (Pfizer)
Boehringer Ingelheim
Merial Inc.
Ceva Animal Health
Elanco
Virbac Inc.
Bayer Animal Health
Heska Corporation
Phibro Animal Health
Objective to buy this Report:
1. Veterinary or Animal Vaccines analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Veterinary or Animal Vaccines market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: VETERINARY OR ANIMAL VACCINES MARKET BY TYPE
5.1 Veterinary or Animal Vaccines Market Overview Snapshot and Growth Engine
5.2 Veterinary or Animal Vaccines Market Overview
5.3 Attenuated Live Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Attenuated Live Vaccines: Geographic Segmentation
5.4 Inactivated Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Inactivated Vaccines: Geographic Segmentation
5.5 Subunit Vaccines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Subunit Vaccines: Geographic Segmentation
5.6 DNA Vaccines
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 DNA Vaccines: Geographic Segmentation
5.7 Recombinant Vaccines
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Recombinant Vaccines: Geographic Segmentation
CHAPTER 6: VETERINARY OR ANIMAL VACCINES MARKET BY APPLICATION
6.1 Veterinary or Animal Vaccines Market Overview Snapshot and Growth Engine
6.2 Veterinary or Animal Vaccines Market Overview
6.3 Porcine Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Porcine Diseases: Geographic Segmentation
6.4 Poultry Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Poultry Diseases: Geographic Segmentation
6.5 Livestock Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Livestock Diseases: Geographic Segmentation
6.6 Companion Animal Diseases
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Companion Animal Diseases: Geographic Segmentation
6.7 Aquaculture Diseases
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2028F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Aquaculture Diseases: Geographic Segmentation
6.8 Other Diseases
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2016-2028F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Other Diseases: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Veterinary or Animal Vaccines Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Veterinary or Animal Vaccines Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Veterinary or Animal Vaccines Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MERCK ANIMAL HEALTH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ELANCO ANIMAL HEALTH
7.4 ZOETIS INC. (PFIZER)
7.5 BOEHRINGER INGELHEIM
7.6 MERIAL INC.
7.7 CEVA ANIMAL HEALTH
7.8 ELANCO
7.9 VIRBAC INC.
7.10 BAYER ANIMAL HEALTH
7.11 HESKA CORPORATION
7.12 PHIBRO ANIMAL HEALTH
CHAPTER 8: GLOBAL VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Attenuated Live Vaccines
8.2.2 Inactivated Vaccines
8.2.3 Subunit Vaccines
8.2.4 DNA Vaccines
8.2.5 Recombinant Vaccines
8.3 Historic and Forecasted Market Size By Application
8.3.1 Porcine Diseases
8.3.2 Poultry Diseases
8.3.3 Livestock Diseases
8.3.4 Companion Animal Diseases
8.3.5 Aquaculture Diseases
8.3.6 Other Diseases
CHAPTER 9: NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Attenuated Live Vaccines
9.4.2 Inactivated Vaccines
9.4.3 Subunit Vaccines
9.4.4 DNA Vaccines
9.4.5 Recombinant Vaccines
9.5 Historic and Forecasted Market Size By Application
9.5.1 Porcine Diseases
9.5.2 Poultry Diseases
9.5.3 Livestock Diseases
9.5.4 Companion Animal Diseases
9.5.5 Aquaculture Diseases
9.5.6 Other Diseases
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Attenuated Live Vaccines
10.4.2 Inactivated Vaccines
10.4.3 Subunit Vaccines
10.4.4 DNA Vaccines
10.4.5 Recombinant Vaccines
10.5 Historic and Forecasted Market Size By Application
10.5.1 Porcine Diseases
10.5.2 Poultry Diseases
10.5.3 Livestock Diseases
10.5.4 Companion Animal Diseases
10.5.5 Aquaculture Diseases
10.5.6 Other Diseases
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Attenuated Live Vaccines
11.4.2 Inactivated Vaccines
11.4.3 Subunit Vaccines
11.4.4 DNA Vaccines
11.4.5 Recombinant Vaccines
11.5 Historic and Forecasted Market Size By Application
11.5.1 Porcine Diseases
11.5.2 Poultry Diseases
11.5.3 Livestock Diseases
11.5.4 Companion Animal Diseases
11.5.5 Aquaculture Diseases
11.5.6 Other Diseases
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Attenuated Live Vaccines
12.4.2 Inactivated Vaccines
12.4.3 Subunit Vaccines
12.4.4 DNA Vaccines
12.4.5 Recombinant Vaccines
12.5 Historic and Forecasted Market Size By Application
12.5.1 Porcine Diseases
12.5.2 Poultry Diseases
12.5.3 Livestock Diseases
12.5.4 Companion Animal Diseases
12.5.5 Aquaculture Diseases
12.5.6 Other Diseases
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Attenuated Live Vaccines
13.4.2 Inactivated Vaccines
13.4.3 Subunit Vaccines
13.4.4 DNA Vaccines
13.4.5 Recombinant Vaccines
13.5 Historic and Forecasted Market Size By Application
13.5.1 Porcine Diseases
13.5.2 Poultry Diseases
13.5.3 Livestock Diseases
13.5.4 Companion Animal Diseases
13.5.5 Aquaculture Diseases
13.5.6 Other Diseases
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: VETERINARY OR ANIMAL VACCINES MARKET BY TYPE
5.1 Veterinary or Animal Vaccines Market Overview Snapshot and Growth Engine
5.2 Veterinary or Animal Vaccines Market Overview
5.3 Attenuated Live Vaccines
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Attenuated Live Vaccines: Geographic Segmentation
5.4 Inactivated Vaccines
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Inactivated Vaccines: Geographic Segmentation
5.5 Subunit Vaccines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Subunit Vaccines: Geographic Segmentation
5.6 DNA Vaccines
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 DNA Vaccines: Geographic Segmentation
5.7 Recombinant Vaccines
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Recombinant Vaccines: Geographic Segmentation
CHAPTER 6: VETERINARY OR ANIMAL VACCINES MARKET BY APPLICATION
6.1 Veterinary or Animal Vaccines Market Overview Snapshot and Growth Engine
6.2 Veterinary or Animal Vaccines Market Overview
6.3 Porcine Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Porcine Diseases: Geographic Segmentation
6.4 Poultry Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Poultry Diseases: Geographic Segmentation
6.5 Livestock Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Livestock Diseases: Geographic Segmentation
6.6 Companion Animal Diseases
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Companion Animal Diseases: Geographic Segmentation
6.7 Aquaculture Diseases
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2028F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Aquaculture Diseases: Geographic Segmentation
6.8 Other Diseases
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2016-2028F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Other Diseases: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Veterinary or Animal Vaccines Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Veterinary or Animal Vaccines Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Veterinary or Animal Vaccines Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MERCK ANIMAL HEALTH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ELANCO ANIMAL HEALTH
7.4 ZOETIS INC. (PFIZER)
7.5 BOEHRINGER INGELHEIM
7.6 MERIAL INC.
7.7 CEVA ANIMAL HEALTH
7.8 ELANCO
7.9 VIRBAC INC.
7.10 BAYER ANIMAL HEALTH
7.11 HESKA CORPORATION
7.12 PHIBRO ANIMAL HEALTH
CHAPTER 8: GLOBAL VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Attenuated Live Vaccines
8.2.2 Inactivated Vaccines
8.2.3 Subunit Vaccines
8.2.4 DNA Vaccines
8.2.5 Recombinant Vaccines
8.3 Historic and Forecasted Market Size By Application
8.3.1 Porcine Diseases
8.3.2 Poultry Diseases
8.3.3 Livestock Diseases
8.3.4 Companion Animal Diseases
8.3.5 Aquaculture Diseases
8.3.6 Other Diseases
CHAPTER 9: NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Attenuated Live Vaccines
9.4.2 Inactivated Vaccines
9.4.3 Subunit Vaccines
9.4.4 DNA Vaccines
9.4.5 Recombinant Vaccines
9.5 Historic and Forecasted Market Size By Application
9.5.1 Porcine Diseases
9.5.2 Poultry Diseases
9.5.3 Livestock Diseases
9.5.4 Companion Animal Diseases
9.5.5 Aquaculture Diseases
9.5.6 Other Diseases
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Attenuated Live Vaccines
10.4.2 Inactivated Vaccines
10.4.3 Subunit Vaccines
10.4.4 DNA Vaccines
10.4.5 Recombinant Vaccines
10.5 Historic and Forecasted Market Size By Application
10.5.1 Porcine Diseases
10.5.2 Poultry Diseases
10.5.3 Livestock Diseases
10.5.4 Companion Animal Diseases
10.5.5 Aquaculture Diseases
10.5.6 Other Diseases
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Attenuated Live Vaccines
11.4.2 Inactivated Vaccines
11.4.3 Subunit Vaccines
11.4.4 DNA Vaccines
11.4.5 Recombinant Vaccines
11.5 Historic and Forecasted Market Size By Application
11.5.1 Porcine Diseases
11.5.2 Poultry Diseases
11.5.3 Livestock Diseases
11.5.4 Companion Animal Diseases
11.5.5 Aquaculture Diseases
11.5.6 Other Diseases
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Attenuated Live Vaccines
12.4.2 Inactivated Vaccines
12.4.3 Subunit Vaccines
12.4.4 DNA Vaccines
12.4.5 Recombinant Vaccines
12.5 Historic and Forecasted Market Size By Application
12.5.1 Porcine Diseases
12.5.2 Poultry Diseases
12.5.3 Livestock Diseases
12.5.4 Companion Animal Diseases
12.5.5 Aquaculture Diseases
12.5.6 Other Diseases
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Attenuated Live Vaccines
13.4.2 Inactivated Vaccines
13.4.3 Subunit Vaccines
13.4.4 DNA Vaccines
13.4.5 Recombinant Vaccines
13.5 Historic and Forecasted Market Size By Application
13.5.1 Porcine Diseases
13.5.2 Poultry Diseases
13.5.3 Livestock Diseases
13.5.4 Companion Animal Diseases
13.5.5 Aquaculture Diseases
13.5.6 Other Diseases
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. VETERINARY OR ANIMAL VACCINES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. VETERINARY OR ANIMAL VACCINES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. VETERINARY OR ANIMAL VACCINES MARKET COMPETITIVE RIVALRY
TABLE 005. VETERINARY OR ANIMAL VACCINES MARKET THREAT OF NEW ENTRANTS
TABLE 006. VETERINARY OR ANIMAL VACCINES MARKET THREAT OF SUBSTITUTES
TABLE 007. VETERINARY OR ANIMAL VACCINES MARKET BY TYPE
TABLE 008. ATTENUATED LIVE VACCINES MARKET OVERVIEW (2016-2028)
TABLE 009. INACTIVATED VACCINES MARKET OVERVIEW (2016-2028)
TABLE 010. SUBUNIT VACCINES MARKET OVERVIEW (2016-2028)
TABLE 011. DNA VACCINES MARKET OVERVIEW (2016-2028)
TABLE 012. RECOMBINANT VACCINES MARKET OVERVIEW (2016-2028)
TABLE 013. VETERINARY OR ANIMAL VACCINES MARKET BY APPLICATION
TABLE 014. PORCINE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 015. POULTRY DISEASES MARKET OVERVIEW (2016-2028)
TABLE 016. LIVESTOCK DISEASES MARKET OVERVIEW (2016-2028)
TABLE 017. COMPANION ANIMAL DISEASES MARKET OVERVIEW (2016-2028)
TABLE 018. AQUACULTURE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 019. OTHER DISEASES MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 022. N VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 023. EUROPE VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 024. EUROPE VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 025. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 026. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 027. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 028. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 031. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 032. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 033. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 034. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 035. MERCK ANIMAL HEALTH: SNAPSHOT
TABLE 036. MERCK ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 037. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 038. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ELANCO ANIMAL HEALTH: SNAPSHOT
TABLE 039. ELANCO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 040. ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 041. ELANCO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. ZOETIS INC. (PFIZER): SNAPSHOT
TABLE 042. ZOETIS INC. (PFIZER): BUSINESS PERFORMANCE
TABLE 043. ZOETIS INC. (PFIZER): PRODUCT PORTFOLIO
TABLE 044. ZOETIS INC. (PFIZER): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. BOEHRINGER INGELHEIM: SNAPSHOT
TABLE 045. BOEHRINGER INGELHEIM: BUSINESS PERFORMANCE
TABLE 046. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 047. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. MERIAL INC.: SNAPSHOT
TABLE 048. MERIAL INC.: BUSINESS PERFORMANCE
TABLE 049. MERIAL INC.: PRODUCT PORTFOLIO
TABLE 050. MERIAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. CEVA ANIMAL HEALTH: SNAPSHOT
TABLE 051. CEVA ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 052. CEVA ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 053. CEVA ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ELANCO: SNAPSHOT
TABLE 054. ELANCO: BUSINESS PERFORMANCE
TABLE 055. ELANCO: PRODUCT PORTFOLIO
TABLE 056. ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. VIRBAC INC.: SNAPSHOT
TABLE 057. VIRBAC INC.: BUSINESS PERFORMANCE
TABLE 058. VIRBAC INC.: PRODUCT PORTFOLIO
TABLE 059. VIRBAC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. BAYER ANIMAL HEALTH: SNAPSHOT
TABLE 060. BAYER ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 061. BAYER ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 062. BAYER ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. HESKA CORPORATION: SNAPSHOT
TABLE 063. HESKA CORPORATION: BUSINESS PERFORMANCE
TABLE 064. HESKA CORPORATION: PRODUCT PORTFOLIO
TABLE 065. HESKA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. PHIBRO ANIMAL HEALTH: SNAPSHOT
TABLE 066. PHIBRO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 067. PHIBRO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 068. PHIBRO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. VETERINARY OR ANIMAL VACCINES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. VETERINARY OR ANIMAL VACCINES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. VETERINARY OR ANIMAL VACCINES MARKET COMPETITIVE RIVALRY
TABLE 005. VETERINARY OR ANIMAL VACCINES MARKET THREAT OF NEW ENTRANTS
TABLE 006. VETERINARY OR ANIMAL VACCINES MARKET THREAT OF SUBSTITUTES
TABLE 007. VETERINARY OR ANIMAL VACCINES MARKET BY TYPE
TABLE 008. ATTENUATED LIVE VACCINES MARKET OVERVIEW (2016-2028)
TABLE 009. INACTIVATED VACCINES MARKET OVERVIEW (2016-2028)
TABLE 010. SUBUNIT VACCINES MARKET OVERVIEW (2016-2028)
TABLE 011. DNA VACCINES MARKET OVERVIEW (2016-2028)
TABLE 012. RECOMBINANT VACCINES MARKET OVERVIEW (2016-2028)
TABLE 013. VETERINARY OR ANIMAL VACCINES MARKET BY APPLICATION
TABLE 014. PORCINE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 015. POULTRY DISEASES MARKET OVERVIEW (2016-2028)
TABLE 016. LIVESTOCK DISEASES MARKET OVERVIEW (2016-2028)
TABLE 017. COMPANION ANIMAL DISEASES MARKET OVERVIEW (2016-2028)
TABLE 018. AQUACULTURE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 019. OTHER DISEASES MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 022. N VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 023. EUROPE VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 024. EUROPE VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 025. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 026. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 027. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 028. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 031. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 032. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY TYPE (2016-2028)
TABLE 033. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET, BY APPLICATION (2016-2028)
TABLE 034. VETERINARY OR ANIMAL VACCINES MARKET, BY COUNTRY (2016-2028)
TABLE 035. MERCK ANIMAL HEALTH: SNAPSHOT
TABLE 036. MERCK ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 037. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 038. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ELANCO ANIMAL HEALTH: SNAPSHOT
TABLE 039. ELANCO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 040. ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 041. ELANCO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. ZOETIS INC. (PFIZER): SNAPSHOT
TABLE 042. ZOETIS INC. (PFIZER): BUSINESS PERFORMANCE
TABLE 043. ZOETIS INC. (PFIZER): PRODUCT PORTFOLIO
TABLE 044. ZOETIS INC. (PFIZER): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. BOEHRINGER INGELHEIM: SNAPSHOT
TABLE 045. BOEHRINGER INGELHEIM: BUSINESS PERFORMANCE
TABLE 046. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 047. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. MERIAL INC.: SNAPSHOT
TABLE 048. MERIAL INC.: BUSINESS PERFORMANCE
TABLE 049. MERIAL INC.: PRODUCT PORTFOLIO
TABLE 050. MERIAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. CEVA ANIMAL HEALTH: SNAPSHOT
TABLE 051. CEVA ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 052. CEVA ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 053. CEVA ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ELANCO: SNAPSHOT
TABLE 054. ELANCO: BUSINESS PERFORMANCE
TABLE 055. ELANCO: PRODUCT PORTFOLIO
TABLE 056. ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. VIRBAC INC.: SNAPSHOT
TABLE 057. VIRBAC INC.: BUSINESS PERFORMANCE
TABLE 058. VIRBAC INC.: PRODUCT PORTFOLIO
TABLE 059. VIRBAC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. BAYER ANIMAL HEALTH: SNAPSHOT
TABLE 060. BAYER ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 061. BAYER ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 062. BAYER ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. HESKA CORPORATION: SNAPSHOT
TABLE 063. HESKA CORPORATION: BUSINESS PERFORMANCE
TABLE 064. HESKA CORPORATION: PRODUCT PORTFOLIO
TABLE 065. HESKA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. PHIBRO ANIMAL HEALTH: SNAPSHOT
TABLE 066. PHIBRO ANIMAL HEALTH: BUSINESS PERFORMANCE
TABLE 067. PHIBRO ANIMAL HEALTH: PRODUCT PORTFOLIO
TABLE 068. PHIBRO ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY TYPE
FIGURE 012. ATTENUATED LIVE VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 013. INACTIVATED VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 014. SUBUNIT VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 015. DNA VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 016. RECOMBINANT VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 017. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY APPLICATION
FIGURE 018. PORCINE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 019. POULTRY DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 020. LIVESTOCK DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 021. COMPANION ANIMAL DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 022. AQUACULTURE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 023. OTHER DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY TYPE
FIGURE 012. ATTENUATED LIVE VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 013. INACTIVATED VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 014. SUBUNIT VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 015. DNA VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 016. RECOMBINANT VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 017. VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY APPLICATION
FIGURE 018. PORCINE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 019. POULTRY DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 020. LIVESTOCK DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 021. COMPANION ANIMAL DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 022. AQUACULTURE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 023. OTHER DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA VETERINARY OR ANIMAL VACCINES MARKET OVERVIEW BY COUNTRY (2016-2028)
